News

Overview of Alpha-1 Antitrypsin Deficiency Alpha-1 antitrypsin (A1AT) is a protein that protects the lungs. The liver produces the protein and it’s released into the bloodstream to reach the lungs.
Alpha-1 antitrypsin (AAT) deficiency is a rare inherited disorder that can lead to serious chronic obstructive pulmonary disease (COPD). While there's no cure, treatments and lifestyle changes can ...
The Alpha-1 Foundation (A1F) is excited to announce the formation of AlphaDetect, a new non-profit subsidiary of A1F, to lead ...
Alpha-1 occurs when there is a lack of a protein in the blood called alpha-1 antitrypsin, or AAT. AAT is primarily produced in the liver and protects the lungs from infection and inhaled irritants.
Three years later, Biggs is a spokesperson for an educational campaign about Alpha-1 Deficiency, and in December, she addressed the American Lung Association's National Board meeting in New Orleans.
About Alpha-1 Antitrypsin Deficiency (AATD) and KRRO-110 AATD is a genetic disorder most commonly caused by a single missense mutation (G-to-A) in the SERPINA1 gene.
BEAM-302 demonstrated safety and efficacy in increasing AAT levels and reducing mutant protein in alpha-1 antitrypsin deficiency patients. Quiver AI Summary Beam Therapeutics announced promising ...
Three years later, Biggs is a spokesperson for an educational campaign about Alpha-1 Deficiency, and in December, she addressed the American Lung Association's National Board meeting in New Orleans.